Upadacitinib Induction Provided Fast Symptom Relief in Ulcerative Colitis
Post-hoc analysis showed symptom relief as early as day 1 with the JAK inhibitor
Source: medpagetoday.com
Stay updated with breaking news from Danaj Lukin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Post-hoc analysis showed symptom relief as early as day 1 with the JAK inhibitor
Older IBD patients with comorbidities are less likely to be hospitalized due to an infection if they are treated with vedolizumab or ustekinumab than with an anti-TNF agent, suggests a US study.
Urgency deserves consideration as a UC-specific patient-reported outcome, researchers say